BLOOMBERG BNA WEBINAR EVENT: Antitrust Implications of Executive Dealing Arrangements
Thursday, September 12, 2013
1:00 PM - 2:00 PM ET
This presentation sets out the potential pro-competitive impact and anti-competitive effects that may result from hospitals or other medical providers agreeing to accept lower reimbursement from insurers in exchange for obtaining the exclusive right to serve the insurers’ members in a given service area.
The faculty will highlight criteria that should be used when determining whether the exclusive right may constitute an unreasonable restraint of trade or act of monopolization.
- Understand the changing landscape of provider-insurer relations and provider-provider relations following implementation of the Affordable Care Act (ACA) and consolidation in the health care provider industry.
- Learn to identify a potential exclusive dealing agreement between a provider and an insurer or between two competing providers, as these agreements can take many forms.
- Assess the potential antitrust dangers of entering into an exclusive dealing agreement with an insurer or another provider.
- Find out how to structure an exclusive agreement in a way that emphasizes the pro-competitive elements of an agreement over the potential anti-competitive effects of that agreement.
Who would benefit most from attending?
Antitrust lawyers; health care lawyers; in-house counsel for hospitals; and in-house counsel for provider associations.
Program Level: Intermediate